CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Epigenomics AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Epigenomics AG
Geneststrasse 5
Phone: +49 30243450p:+49 30243450 BERLIN, 10829  Germany Ticker: ECXECX
Business Summary
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. It also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The Company is present in Europe and the United States.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairwoman of the Supervisory Board HelgeLubenow 56 2/15/2023 5/25/2016
President, Chief Scientific Officer Andrew A.Lukowiak 12/1/2021 12/1/2021
Deputy Chairman of the Supervisory Board AlexanderLink 53 6/16/2021 6/1/2020
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Epigenomics Inc. 11055 Flintkote Avenue San Diego CA United States

Business Names
Business Name
0Q2O
0QXH
ECX
6 additional Business Names available in full report.

General Information
Number of Employees: 18 (As of 6/30/2023)
Outstanding Shares: 875,150 (As of 4/9/2024)
Stock Exchange: FRA
Fax Number: +49 3024345555


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024